Immune approaches in tuberculosis therapy: a brief overview

Area of Science:

• Immunology
• Microbiology
• Medical History

Background:

• Tuberculosis (TB) affects one-third of the global population, caused by Mycobacterium tuberculosis.
• Overt clinical disease is triggered by various factors, with host immune response, particularly destructive inflammation, playing a major role.
• Conventional chemotherapy addresses bacterial load but not immunopathological changes, necessitating immunotherapy.

Purpose of the Study:

• To review the historical and modern approaches to tuberculosis immunotherapy.
• To highlight the importance of empirical evidence in guiding scientific progress.
• To discuss the role of the host immune response in TB pathogenesis and treatment.

Main Methods:

• Literature review of historical medical texts and scientific publications.
• Analysis of clinical experiences and trial-and-error processes in immunotherapy.
• Retrospective examination of early therapeutic interventions for TB.

Main Results:

• Early empirical treatments, such as Li Shi Chen's recommendation in the Pên Ts'ao Kang Mu, suggest historical use of heat-killed mycobacteria for TB.
• Robert Koch's tuberculin therapy in 1890 marked a significant, though not entirely successful, step in TB immunotherapy.
• Despite numerous attempts, identifying optimal immune interventions for TB remains challenging.

Conclusions:

• Immunotherapy holds potential for correcting immunopathological changes in TB.
• Historical empirical evidence, though unconventional, offers valuable insights for modern scientific approaches.
• Further research integrating historical knowledge with modern science is crucial for advancing TB immunotherapy.